Reviewers note that it's practical and affordable.

Joseph Anaya, MD, and Ashkan Abbey, MD, discuss how retina specialists identify appropriate candidates for complement inhibitor therapy in geographic atrophy, set patient expectations, and monitor ...

SEATTLE, Feb. 25, 2026 /PRNewswire/ -- Valant, the leading provider of behavioral health EHR software, today announced expanded capabilities for its AI-powered clinical documentation tool, AI Notes ...

When we think of mental health, we typically think of one-on-one counseling services between a patient and a licensed clinician. But in addition to standard psychotherapy, people of all ages can ...

Imagine this: your desk is clutter-free, your ideas are neatly categorized, and your to-dos are effortlessly synced across all your devices. Sounds like a productivity dream, right? That’s exactly ...

Why Democrats’ upset in a Texas state Senate race is a big deal Latest batch of Epstein files has global impact Enormous freshwater reservoir discovered off the East Coast may be 20,000 years old and ...

I’ve spent most of my life caring for others. By 25, I had three children, including premature twins. One was born with severe cerebral palsy – she needed feeding for 12 hours daily in her first year, ...

How would you feel if your therapist’s notes – your darkest thoughts and deepest feelings – were exposed to the world? For 33,000 Finnish people, that became a terrifying reality, with deadly ...

Intrigue: Ransom Man explores the shocking true story behind thousands of private therapy notes that were leaked online What if your deepest secrets were held to ransom? Author and presenter Jenny ...

In December 2025, Baxter International Inc. completed the final settlement of its cash tender offers, retiring all of its 2.600% senior unsecured notes due 2026 and purchasing a substantial portion of ...

Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...